How to treat constipation: The 11 foods to AVOID when constipated
CONSTIPATION isn't usually anything to worry about and is normally easily fixed, starting with changes to your diet. Here are 11 foods to avoid when constipated. (Source: Daily Express - Health)
Source: Daily Express - Health - July 21, 2021 Category: Consumer Health News Source Type: news

Enulose (Lactulose Solution) - updated on RxList
Enulose (lactulose) Solution is used to treat chronic constipation. Learn side effects, dosage, drug interactions, warnings, patient labeling, reviews, and more. (Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 21, 2021 Category: Drugs & Pharmacology Source Type: news

Constipation, flatulence, burping, and more: Is something wrong?
Yale doctors share some of the GI issues they frequently treat, suggest steps you can take at home — and explain when you should seek advice from a physician. (Source: Yale Science and Health News)
Source: Yale Science and Health News - July 15, 2021 Category: Universities & Medical Training Source Type: news

What causes constipation? The two drinks you should AVOID
CONSTIPATION is a common problem where you can't manage to go to the toilet enough. But what causes it and are there certain foods and drinks to avoid? (Source: Daily Express - Health)
Source: Daily Express - Health - July 15, 2021 Category: Consumer Health News Source Type: news

A Closer Look at the Colon Condition That Hospitalized the Pope
Francis suffered a disorder that is relatively common and treatable, and doctors expect him to make a full recovery. (Source: NYT Health)
Source: NYT Health - July 5, 2021 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Colon Digestive Tract Surgery and Surgeons Antibiotics Constipation Fiber (Dietary) Diverticulosis Age, Chronological Roman Catholic Church Gemelli Francis Source Type: news

How to deal with common digestive problems
Stomach woes become more common with age. Lifestyle changes can make a big difference with heartburn, bloating, constipation, gas and lactose intolerance. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - June 28, 2021 Category: Consumer Health News Authors: Sally Wadyka Source Type: news

Janssen Announces Results from Phase 3 MAIA Study Showing Significant Overall Survival Benefits for Treatment with DARZALEX ® (daratumumab) in Patients with Newly Diagnosed Multiple Myeloma Who are Transplant Ineligible
Raritan, N.J., June 12, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced overall survival (OS) results from the Phase 3 MAIA (NCT02252172) study showing the addition of DARZALEX® (daratumumab) to lenalidomide and dexamethasone (D-Rd) resulted in a statistically significant survival benefit over lenalidomide and dexamethasone (Rd) alone in patients with newly diagnosed multiple myeloma (NDMM) who were ineligible for autologous stem cell transplant (ASCT) and were treated to progression.[1] These data were featured in the European Hematology Association (EHA) 2021 Virtual Press Briefin...
Source: Johnson and Johnson - June 12, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Highlights Commitment to Advancing Transformative Innovations in Oncology with Scientific Updates from Deep, Diverse Pipeline and Portfolio at ASCO and EHA Virtual Scientific Programs
June 1, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 30 company-sponsored studies, including six oral presentations, will be featured during the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, June 4-8. Janssen presentations will include new data and updates for both approved and investigational therapeutics that are being studied for the treatment of various solid tumors and blood cancers. Immediately following ASCO, additional data will be featured during the European Hematology Association (EHA) Virtual Congress, June 9-17. A ...
Source: Johnson and Johnson - June 1, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Is Constipation Normal in the First Trimester
Is It Normal to Be Constipated in the First Trimester? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - May 27, 2021 Category: General Medicine Source Type: news

Updated Data Demonstrate Significant Improvement in Hematologic Complete Response with DARZALEX FASPRO ® (daratumumab and hyaluronidase-fihj) in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis
RARITAN, N.J., May 26, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced updated results from the Phase 3 ANDROMEDA study, which evaluated DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for the treatment of patients with newly diagnosed light chain (AL) amyloidosis, a rare blood cell disorder associated with the deterioration of vital organs, most notably the heart, kidneys and liver.[1] Longer-term results from a median follow-up of 20.3 months showed rates of hematologic complete response (hemCR) remained significantly higher in patients treated with DARZALEX FASPRO®...
Source: Johnson and Johnson - May 26, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

RYBREVANTTM (amivantamab-vmjw) Receives FDA Approval as the First Targeted Treatment for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
May 21, 2021 (HORSHAM, P.A.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) has granted the accelerated approval of RYBREVANTTM (amivantamab-vmjw) for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test, whose disease has progressed on or after platinum-based chemotherapy.[1] RYBREVANTTM is the first fully-human, bispecific antibody approved for the treatment of patients with NSCLC t...
Source: Johnson and Johnson - May 21, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Emergency medicine: 9 Healing herbs to grow at home before SHTF
(Natural News) Healing herbs are every prepper’s go-to medicines when SHTF. These natural medicines have been used for centuries to treat a variety of ailments, such as wounds, fever and constipation. On top of that, many medicinal herbs are quite easy to grow and require very little maintenance. Watering them every now and then and ensuring that they... (Source: NaturalNews.com)
Source: NaturalNews.com - May 6, 2021 Category: Consumer Health News Source Type: news

Healing Words: The Opioid-Induced Constipation Crisis
No abstract available (Source: Emergency Medicine News)
Source: Emergency Medicine News - May 1, 2021 Category: Emergency Medicine Tags: Healing Words Source Type: news

Three More Things We Do for No Reason in Pediatrics Three More Things We Do for No Reason in Pediatrics
The Cribsiders share their favorite easy-to-implement pearls on CAP, cellulitis, and constipation in kids.The Cribsiders (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 30, 2021 Category: Consumer Health News Tags: Pediatrics Commentary Source Type: news

Get Moving on Constipation
Dear Dr. Jeff: Recently our facility had a patient who complained of abdominal pain and vomiting. She was sent to the emergency department where she received a Fleet enema and was returned with a diagnosis of “fecal impaction.” The family complained to surveyors who cited us for a Level G deficiency and imposed a $5,000 fine. The facility leadership has focused on the decision to transfer the resident to the hospital as the problem, but it seems to me that more needs to be fixed. Any suggestions? (Source: Caring for the Ages)
Source: Caring for the Ages - April 28, 2021 Category: Health Management Authors: Jeffrey Nichols Tags: Dear Dr. Jeff Source Type: news

Dramatic Rise in Use of Drugs for Opioid-Induced Constipation Dramatic Rise in Use of Drugs for Opioid-Induced Constipation
Use of these drugs soared during a period of 4 years, propelled by a Super Bowl advertisement, prompting calls for defining appropriate use of these agents.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 27, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Diabetes type 2 symptoms: Constipation may indicate nerve damage
DIABETES may continue to disrupt your internal processes, with symptoms so slight, you don't realise the significant damage being done inside. Struggling to release bowel movements might be more sinister than once thought. (Source: Daily Express - Health)
Source: Daily Express - Health - April 18, 2021 Category: Consumer Health News Source Type: news

Constipation treatment Vibrant raises $7.5 million led by Unorthodox Ventures
Sequoia Capital invests for fourth time as treatment continues third round of FDA trials YOKNEAM ILLIT, Israel, March 26, 2021 -- (Healthcare Sales & Marketing Network) -- Vibrant, a leading developer of gastrointestinal treatments, today announced the... Devices, Gastroenterology, Venture Capital Vibrant Ltd, vibrating capsule (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 26, 2021 Category: Pharmaceuticals Source Type: news

What Are Generalized Anxiety Disorder Treatment Components?
Discussion Generalized anxiety disorder (GAD) is “…excessive anxiety and worry about a number of events and activities coupled with at least one physical symptom, which may include fatigue, poor concentration, restlessness, irritability, muscle tension, and sleep difficulties.” Other ways it presents to the primary care office may be abdominal pain, headache or heart palpitations, dizziness, syncope, numbness, trembling, paresthesia, memory loss, or urinary frequency. It has an estimated prevalence of 15% and is the second most common anxiety disorder in children after social anxiety disorder. GAD can co...
Source: PediatricEducation.org - March 15, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

FDA qualifies C-Path's Diary for Irritable Bowel Syndrome Symptoms-Constipation (DIBSS-C)
(Critical Path Institute (C-Path)) C-Path Patient-Reported Outcome Consortium announces the qualification of the Diary for Irritable Bowel Syndrome Symptoms-Constipation by FDA. The DIBSS-C was developed by the PRO Consortium's Irritable Bowel Syndrome Working Group to support symptom-based efficacy endpoints in clinical trials for products intended to treat constipation-predominant IBS in adults. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 9, 2021 Category: International Medicine & Public Health Source Type: news

Splinting: What is it and is the TikTok constipation hack dangerous?
SPLINTING is not a new thing and according to TikTok users, it's an effective hack to solve constipation. But is splinting dangerous? (Source: Daily Express - Health)
Source: Daily Express - Health - March 4, 2021 Category: Consumer Health News Source Type: news

What Is the Difference Between Fecal Impaction and Constipation?
Title: What Is the Difference Between Fecal Impaction and Constipation?Category: Diseases and ConditionsCreated: 3/4/2021 12:00:00 AMLast Editorial Review: 3/4/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - March 4, 2021 Category: Nutrition Source Type: news

Antidepressants could be prescribed by GPs as the new weapon in the war on Irritable Bowel Syndrome
IBS affects nine million Britons, causing agonising pain, bloating, diarrhoea and constipation - with few effective treatments available. (Source: the Mail online | Health)
Source: the Mail online | Health - February 27, 2021 Category: Consumer Health News Source Type: news

Roche receives positive CHMP opinion for Evrysdi, the first and only at home spinal muscular atrophy (SMA) treatment with proven efficacy in adults, children and infants two months and older
Basel, 26 February 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Evrysdi ™ (risdiplam) for the treatment of 5q spinal muscular atrophy (SMA) in patients 2 months of age and older, with a clinical diagnosis of SMA Type 1, Type 2 or Type 3 or with one to four SMN2 copies. SMA is a leading genetic cause of death in infants and 5q SMA is the most common form of the disease . SMA causes progressive muscle weakness and atrophy, and significant unmet need remains, particularly in adults ...
Source: Roche Media News - February 26, 2021 Category: Pharmaceuticals Source Type: news

Roche receives positive CHMP opinion for Evrysdi, the first and only at home spinal muscular atrophy (SMA) treatment with proven efficacy in adults, children and infants two months and older
Basel, 26 February 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Evrysdi ™ (risdiplam) for the treatment of 5q spinal muscular atrophy (SMA) in patients 2 months of age and older, with a clinical diagnosis of SMA Type 1, Type 2 or Type 3 or with one to four SMN2 copies. SMA is a leading genetic cause of death in infants and 5q SMA is the most common form of the disease . SMA causes progressive muscle weakness and atrophy, and significant unmet need remains, particularly in adults ...
Source: Roche Investor Update - February 26, 2021 Category: Pharmaceuticals Source Type: news

What Can Constipation be a Sign Of?
Title: What Can Constipation be a Sign Of?Category: Diseases and ConditionsCreated: 2/24/2021 12:00:00 AMLast Editorial Review: 2/24/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - February 24, 2021 Category: Nutrition Source Type: news

Toxic Clostridioides (formerly Clostridium) difficile colitis: No longer a diarrhea associated infection, American journal of surgery 221(1): 240-242
Conclusion: CDI must be suspected in patients who rapidly develop abdominal distention, vague abdominal complaints or change in bowel function even in the absence of diarrhea, especially if coupled with multi-system organ failure. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 19, 2021 Category: Consumer Health News Source Type: news

Constipation Remedies
Title: Constipation RemediesCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 2/18/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - February 18, 2021 Category: Nutrition Source Type: news

Prostate cancer: Stomach pain, constipation or blood in stools are signs not to ignore
PROSTATE cancer is the most common cancer in men in the UK, with around 40,000 men diagnosed with prostate cancer every year in England alone. Symptoms can take years to surface and when the cancer has advanced there are three warning signs you should not ignore. (Source: Daily Express - Health)
Source: Daily Express - Health - February 12, 2021 Category: Consumer Health News Source Type: news

What Are Some Home Remedies I Can Give My Child for Constipation?
Title: What Are Some Home Remedies I Can Give My Child for Constipation?Category: Diseases and ConditionsCreated: 2/10/2021 12:00:00 AMLast Editorial Review: 2/10/2021 12:00:00 AM (Source: MedicineNet Kids Health General)
Source: MedicineNet Kids Health General - February 10, 2021 Category: Pediatrics Source Type: news

Janssen to Highlight Robust Solid Tumor Portfolio and Pipeline at 2021 ASCO GU
February 2, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it will highlight the depth of its solid tumor portfolio at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium with 12 data presentations, including three company-sponsored oral presentations from the ERLEADA® (apalutamide) clinical development program. The virtual meeting will take place February 11-13, 2021. “We are committed to the development of innovative therapies for patients with genitourinary cancers for whom there remains a high unmet need,” said C...
Source: Johnson and Johnson - February 2, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Elobixibat: A Novel Treatment for Chronic Constipation Elobixibat: A Novel Treatment for Chronic Constipation
Elobixibat, a novel ileal bile acid transport inhibitor, appears to be a safe and effective treatment for chronic constipation.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 27, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

DDT COA #000005: Diary for Irritable Bowel Syndrome Symptoms – Constipation (DIBSS-C)
DDT COA #000005: Diary for Irritable Bowel Syndrome Symptoms – Constipation (DIBSS-C) (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 26, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

What Helps Constipation Fast?
Title: What Helps Constipation Fast?Category: Diseases and ConditionsCreated: 1/25/2021 12:00:00 AMLast Editorial Review: 1/25/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - January 25, 2021 Category: Nutrition Source Type: news

Is Constipation a Symptom of Cancer
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - January 21, 2021 Category: General Medicine Source Type: news

DARZALEX FASPRO ® (daratumumab and hyaluronidase-fihj) Becomes the First FDA-Approved Treatment for Patients with Newly Diagnosed Light Chain (AL) Amyloidosis
January 15, 2021 (HORSHAM, Pa.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj), a subcutaneous formulation of daratumumab, in combination with bortezomib, cyclophosphamide and dexamethasone (D-VCd) for the treatment of adult patients with newly diagnosed light chain (AL) amyloidosis.[1] DARZALEX FASPRO® is the first and only FDA-approved treatment for patients with this blood cell disorder that is associated with the production of an abnormal protein, which leads to th...
Source: Johnson and Johnson - January 16, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Cost of Constipation Report
In 2018/2019, 76,929 people were admitted in England with constipation, equivalent to 211 people a day and £ 168m was spent by NHS England on treating the condition, which is made up of emergency admissions and laxative prescriptions; these figures have increased since 2017/2018. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 15, 2021 Category: Consumer Health News Source Type: news

Cost of constipation still rising in most English regions
The Cost of Constipation report published by the multidisciplinary organisation, the independent Bowel Interest Group, reveals that the cost of avoidable emergency admissions to hospital because of constipation is rising year-on-year in most English regions. (Source: NHS Networks)
Source: NHS Networks - January 14, 2021 Category: UK Health Source Type: news

C-Path PRO Consortium measure used to support an FDA-approved label claim
(Critical Path Institute (C-Path)) C-Path Patient-Reported Outcome Consortium announces that clinical study results using the Consortium's Diary for Irritable Bowel Syndrome Symptoms-Constipation (DIBSS-C) were recently included in the expanded label for the drug LINZESS ® . (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 7, 2021 Category: International Medicine & Public Health Source Type: news

Boost your gut feeling: From a tummy massager to a tracker app, which is the best for IBS? 
JO WATERS: Irritable bowel syndrome (IBS) affects one in ten adults in the UK, causing bloating, diarrhoea, constipation and cramps. We asked a professor to assess some new products to treat it. (Source: the Mail online | Health)
Source: the Mail online | Health - January 5, 2021 Category: Consumer Health News Source Type: news

Heart disease: Constipation could be a lesser-known warning sign of the condition
HEART disease: There are around 7.4 million people living with heart disease according to the British Heart Foundation. Knowing the warning signs and symptoms is crucial. Could your constipation be one of those warnings? (Source: Daily Express - Health)
Source: Daily Express - Health - December 28, 2020 Category: Consumer Health News Source Type: news

Why am I constipated? The five reasons you could be constipated
CONSTIPATION has many possible causes - emotional and physical. What causes constipation? (Source: Daily Express - Health)
Source: Daily Express - Health - December 28, 2020 Category: Consumer Health News Source Type: news

What causes constipation? The five reasons you could be constipated
CONSTIPATION has many possible causes - emotional and physical. What causes constipation? (Source: Daily Express - Health)
Source: Daily Express - Health - December 27, 2020 Category: Consumer Health News Source Type: news

Bowel cancer symptoms: ‘Alternating bouts of constipation and diarrhoea’ could be a sign
BOWEL cancer symptoms can be subtle and easily-missed, but as there's currently no cure it's important to be familiar with what to look out for. One of the most common signs is a change of bowel habits - "alternating bouts of constipation and diarrhoea". (Source: Daily Express - Health)
Source: Daily Express - Health - December 25, 2020 Category: Consumer Health News Source Type: news

How Can You Tell if Your Baby Is Constipated?
Title: How Can You Tell if Your Baby Is Constipated?Category: Diseases and ConditionsCreated: 12/17/2020 12:00:00 AMLast Editorial Review: 12/17/2020 12:00:00 AM (Source: MedicineNet Kids Health General)
Source: MedicineNet Kids Health General - December 17, 2020 Category: Pediatrics Source Type: news

New treatment in development for irritable bowel syndrome with constipation
(Brigham and Women's Hospital) Researchers devised a plan to treat IBS with constipation by delivering chenodeoxycholic acid in a bilayered capsule, finding that this mode of delivery could decrease colon cramping and thus produce a better patient experience. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 8, 2020 Category: International Medicine & Public Health Source Type: news

Home Remedies for Constipation
Title: Home Remedies for ConstipationCategory: Diseases and ConditionsCreated: 12/3/2020 12:00:00 AMLast Editorial Review: 12/3/2020 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - December 3, 2020 Category: Nutrition Source Type: news

Does your anxiety trigger IBS symptoms? How to support your digestive system
IRRITABLE bowel syndrome is a common condition that affects the digestive system, causing pain, bloating diarrhoea and constipation. Over the years experts have identified stress as a cause. So what can you do to help avoid a flare-up of symptoms? (Source: Daily Express - Health)
Source: Daily Express - Health - November 24, 2020 Category: Consumer Health News Source Type: news

Rapid Relief of Opioid-Induced Constipation With MNTX Rapid Relief of Opioid-Induced Constipation With MNTX
Subcutaneous use of methylnaltrexone (MNTX) provides rapid relief both for patients with chronic noncancer pain and for those with cancer-related illness.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 20, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Janssen Headlines American Society of Hematology Annual Meeting With More Than 35 Presentations Highlighting Deep, Diverse Oncology Pipeline and Portfolio
RARITAN, N.J., November 5, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today more than 35 company-sponsored studies, including 10 oral presentations, will be featured at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition taking place virtually December 5-8, 2020.In multiple myeloma, highlights include Phase 1b/2 results for the B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor T-cell (CAR-T) therapy ciltacabtagene autoleucel (cilta-cel); new and updated data for the anti-CD38 monoclonal antibody DARZALEX® (daratumumab) and the subcutane...
Source: Johnson and Johnson - November 5, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news